ADPD 2025 Presentation

2025 ADPD:

Sabirnetug overview and use of a pTau217 Assay as a Marker of Amyloid Burden for Screening Participants in an Ongoing Phase 2 Study, ALTITUDE-AD.

File Type: pdf
File Size: 3 MB
Categories: 2025
Tags: ALTITUDE-AD, Presentation, pTau217, sabirnetug, TwentyTwentyFive